dpbs Search Results


99
Thermo Fisher phosphate buffered saline
Phosphate Buffered Saline, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphate buffered saline/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
phosphate buffered saline - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

92
Teknova technological development
Technological Development, supplied by Teknova, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/technological development/product/Teknova
Average 92 stars, based on 1 article reviews
technological development - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

97
Valiant Co Ltd phosphate buffered saline
Phosphate Buffered Saline, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphate buffered saline/product/Valiant Co Ltd
Average 97 stars, based on 1 article reviews
phosphate buffered saline - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

93
Valiant Co Ltd dpbs
Dpbs, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dpbs/product/Valiant Co Ltd
Average 93 stars, based on 1 article reviews
dpbs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
GE Healthcare magnesium
Magnesium, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/magnesium/product/GE Healthcare
Average 93 stars, based on 1 article reviews
magnesium - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

91
GE Healthcare dpbs
Dpbs, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dpbs/product/GE Healthcare
Average 91 stars, based on 1 article reviews
dpbs - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

93
MedChemExpress dpbs buffer
Fig. 5. Introducing a disulfide bond between the ARM and SAM domains inhibited M1 or NMN- mediated SARM1 activation. (A) Cell survival rates in HeLa-SARM1−/− cells (Vector) and HeLa-SARM1−/− cells ectopically expressing SARM1 or SARM1 cysteine mutants, treated with 10 μM G10 for 24 h, determined by measuring ATP levels. Data are represented as mean ± SD from triplicate wells. (B) Time course of the base exchange activities of the purified SARM1 (WT) or SARM1 (2Cmut) incubated with <t>DPBS</t> or M1. Each bar represents mean ± SD, n = 3. ****P < 0.0001, n.s., not significant. (C and D) <t>Relative</t> <t>NAD+</t> (C) and cADPR (D) levels in the reaction mixture containing purified SARM1 WT (Top) or 2Cmut (Bottom) incubated with increasing concentrations of NMN or M1 for 30 min. Each bar represents mean ± SD, n = 3. (E) Cryo-EM map of SARM1 2Cmut in complex with M1. The model is fitted in the map. (F) Comparison of structures of SARM1 WT (colored in yellow) and 2Cmut (colored by domains) in complex with M1. (G) Close-up view of the secondary binding interface. A portion of the BB loop (e.g., D605 and E604) in the structure of 2Cmut is resolved through interactions with the ARM domain (e.g., K173). (H) EM density of the disulfide bond in the 2Cmut at a contour level of 4σ.
Dpbs Buffer, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dpbs buffer/product/MedChemExpress
Average 93 stars, based on 1 article reviews
dpbs buffer - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

97
Lonza dulbecco
Fig. 5. Introducing a disulfide bond between the ARM and SAM domains inhibited M1 or NMN- mediated SARM1 activation. (A) Cell survival rates in HeLa-SARM1−/− cells (Vector) and HeLa-SARM1−/− cells ectopically expressing SARM1 or SARM1 cysteine mutants, treated with 10 μM G10 for 24 h, determined by measuring ATP levels. Data are represented as mean ± SD from triplicate wells. (B) Time course of the base exchange activities of the purified SARM1 (WT) or SARM1 (2Cmut) incubated with <t>DPBS</t> or M1. Each bar represents mean ± SD, n = 3. ****P < 0.0001, n.s., not significant. (C and D) <t>Relative</t> <t>NAD+</t> (C) and cADPR (D) levels in the reaction mixture containing purified SARM1 WT (Top) or 2Cmut (Bottom) incubated with increasing concentrations of NMN or M1 for 30 min. Each bar represents mean ± SD, n = 3. (E) Cryo-EM map of SARM1 2Cmut in complex with M1. The model is fitted in the map. (F) Comparison of structures of SARM1 WT (colored in yellow) and 2Cmut (colored by domains) in complex with M1. (G) Close-up view of the secondary binding interface. A portion of the BB loop (e.g., D605 and E604) in the structure of 2Cmut is resolved through interactions with the ARM domain (e.g., K173). (H) EM density of the disulfide bond in the 2Cmut at a contour level of 4σ.
Dulbecco, supplied by Lonza, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dulbecco/product/Lonza
Average 97 stars, based on 1 article reviews
dulbecco - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

94
Bio-Techne corporation trima cones
Fig. 5. Introducing a disulfide bond between the ARM and SAM domains inhibited M1 or NMN- mediated SARM1 activation. (A) Cell survival rates in HeLa-SARM1−/− cells (Vector) and HeLa-SARM1−/− cells ectopically expressing SARM1 or SARM1 cysteine mutants, treated with 10 μM G10 for 24 h, determined by measuring ATP levels. Data are represented as mean ± SD from triplicate wells. (B) Time course of the base exchange activities of the purified SARM1 (WT) or SARM1 (2Cmut) incubated with <t>DPBS</t> or M1. Each bar represents mean ± SD, n = 3. ****P < 0.0001, n.s., not significant. (C and D) <t>Relative</t> <t>NAD+</t> (C) and cADPR (D) levels in the reaction mixture containing purified SARM1 WT (Top) or 2Cmut (Bottom) incubated with increasing concentrations of NMN or M1 for 30 min. Each bar represents mean ± SD, n = 3. (E) Cryo-EM map of SARM1 2Cmut in complex with M1. The model is fitted in the map. (F) Comparison of structures of SARM1 WT (colored in yellow) and 2Cmut (colored by domains) in complex with M1. (G) Close-up view of the secondary binding interface. A portion of the BB loop (e.g., D605 and E604) in the structure of 2Cmut is resolved through interactions with the ARM domain (e.g., K173). (H) EM density of the disulfide bond in the 2Cmut at a contour level of 4σ.
Trima Cones, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trima cones/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
trima cones - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Valiant Co Ltd 1x dulbecco
Fig. 5. Introducing a disulfide bond between the ARM and SAM domains inhibited M1 or NMN- mediated SARM1 activation. (A) Cell survival rates in HeLa-SARM1−/− cells (Vector) and HeLa-SARM1−/− cells ectopically expressing SARM1 or SARM1 cysteine mutants, treated with 10 μM G10 for 24 h, determined by measuring ATP levels. Data are represented as mean ± SD from triplicate wells. (B) Time course of the base exchange activities of the purified SARM1 (WT) or SARM1 (2Cmut) incubated with <t>DPBS</t> or M1. Each bar represents mean ± SD, n = 3. ****P < 0.0001, n.s., not significant. (C and D) <t>Relative</t> <t>NAD+</t> (C) and cADPR (D) levels in the reaction mixture containing purified SARM1 WT (Top) or 2Cmut (Bottom) incubated with increasing concentrations of NMN or M1 for 30 min. Each bar represents mean ± SD, n = 3. (E) Cryo-EM map of SARM1 2Cmut in complex with M1. The model is fitted in the map. (F) Comparison of structures of SARM1 WT (colored in yellow) and 2Cmut (colored by domains) in complex with M1. (G) Close-up view of the secondary binding interface. A portion of the BB loop (e.g., D605 and E604) in the structure of 2Cmut is resolved through interactions with the ARM domain (e.g., K173). (H) EM density of the disulfide bond in the 2Cmut at a contour level of 4σ.
1x Dulbecco, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1x dulbecco/product/Valiant Co Ltd
Average 93 stars, based on 1 article reviews
1x dulbecco - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Lonza dpbs2/2
Fig. 5. Introducing a disulfide bond between the ARM and SAM domains inhibited M1 or NMN- mediated SARM1 activation. (A) Cell survival rates in HeLa-SARM1−/− cells (Vector) and HeLa-SARM1−/− cells ectopically expressing SARM1 or SARM1 cysteine mutants, treated with 10 μM G10 for 24 h, determined by measuring ATP levels. Data are represented as mean ± SD from triplicate wells. (B) Time course of the base exchange activities of the purified SARM1 (WT) or SARM1 (2Cmut) incubated with <t>DPBS</t> or M1. Each bar represents mean ± SD, n = 3. ****P < 0.0001, n.s., not significant. (C and D) <t>Relative</t> <t>NAD+</t> (C) and cADPR (D) levels in the reaction mixture containing purified SARM1 WT (Top) or 2Cmut (Bottom) incubated with increasing concentrations of NMN or M1 for 30 min. Each bar represents mean ± SD, n = 3. (E) Cryo-EM map of SARM1 2Cmut in complex with M1. The model is fitted in the map. (F) Comparison of structures of SARM1 WT (colored in yellow) and 2Cmut (colored by domains) in complex with M1. (G) Close-up view of the secondary binding interface. A portion of the BB loop (e.g., D605 and E604) in the structure of 2Cmut is resolved through interactions with the ARM domain (e.g., K173). (H) EM density of the disulfide bond in the 2Cmut at a contour level of 4σ.
Dpbs2/2, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dpbs2/2/product/Lonza
Average 90 stars, based on 1 article reviews
dpbs2/2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cambrex dpbs
Fig. 5. Introducing a disulfide bond between the ARM and SAM domains inhibited M1 or NMN- mediated SARM1 activation. (A) Cell survival rates in HeLa-SARM1−/− cells (Vector) and HeLa-SARM1−/− cells ectopically expressing SARM1 or SARM1 cysteine mutants, treated with 10 μM G10 for 24 h, determined by measuring ATP levels. Data are represented as mean ± SD from triplicate wells. (B) Time course of the base exchange activities of the purified SARM1 (WT) or SARM1 (2Cmut) incubated with <t>DPBS</t> or M1. Each bar represents mean ± SD, n = 3. ****P < 0.0001, n.s., not significant. (C and D) <t>Relative</t> <t>NAD+</t> (C) and cADPR (D) levels in the reaction mixture containing purified SARM1 WT (Top) or 2Cmut (Bottom) incubated with increasing concentrations of NMN or M1 for 30 min. Each bar represents mean ± SD, n = 3. (E) Cryo-EM map of SARM1 2Cmut in complex with M1. The model is fitted in the map. (F) Comparison of structures of SARM1 WT (colored in yellow) and 2Cmut (colored by domains) in complex with M1. (G) Close-up view of the secondary binding interface. A portion of the BB loop (e.g., D605 and E604) in the structure of 2Cmut is resolved through interactions with the ARM domain (e.g., K173). (H) EM density of the disulfide bond in the 2Cmut at a contour level of 4σ.
Dpbs, supplied by Cambrex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dpbs/product/Cambrex
Average 90 stars, based on 1 article reviews
dpbs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 5. Introducing a disulfide bond between the ARM and SAM domains inhibited M1 or NMN- mediated SARM1 activation. (A) Cell survival rates in HeLa-SARM1−/− cells (Vector) and HeLa-SARM1−/− cells ectopically expressing SARM1 or SARM1 cysteine mutants, treated with 10 μM G10 for 24 h, determined by measuring ATP levels. Data are represented as mean ± SD from triplicate wells. (B) Time course of the base exchange activities of the purified SARM1 (WT) or SARM1 (2Cmut) incubated with DPBS or M1. Each bar represents mean ± SD, n = 3. ****P < 0.0001, n.s., not significant. (C and D) Relative NAD+ (C) and cADPR (D) levels in the reaction mixture containing purified SARM1 WT (Top) or 2Cmut (Bottom) incubated with increasing concentrations of NMN or M1 for 30 min. Each bar represents mean ± SD, n = 3. (E) Cryo-EM map of SARM1 2Cmut in complex with M1. The model is fitted in the map. (F) Comparison of structures of SARM1 WT (colored in yellow) and 2Cmut (colored by domains) in complex with M1. (G) Close-up view of the secondary binding interface. A portion of the BB loop (e.g., D605 and E604) in the structure of 2Cmut is resolved through interactions with the ARM domain (e.g., K173). (H) EM density of the disulfide bond in the 2Cmut at a contour level of 4σ.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Stepwise activation of SARM1 for cell death and axon degeneration revealed by a biosynthetic NMN mimic.

doi: 10.1073/pnas.2424906122

Figure Lengend Snippet: Fig. 5. Introducing a disulfide bond between the ARM and SAM domains inhibited M1 or NMN- mediated SARM1 activation. (A) Cell survival rates in HeLa-SARM1−/− cells (Vector) and HeLa-SARM1−/− cells ectopically expressing SARM1 or SARM1 cysteine mutants, treated with 10 μM G10 for 24 h, determined by measuring ATP levels. Data are represented as mean ± SD from triplicate wells. (B) Time course of the base exchange activities of the purified SARM1 (WT) or SARM1 (2Cmut) incubated with DPBS or M1. Each bar represents mean ± SD, n = 3. ****P < 0.0001, n.s., not significant. (C and D) Relative NAD+ (C) and cADPR (D) levels in the reaction mixture containing purified SARM1 WT (Top) or 2Cmut (Bottom) incubated with increasing concentrations of NMN or M1 for 30 min. Each bar represents mean ± SD, n = 3. (E) Cryo-EM map of SARM1 2Cmut in complex with M1. The model is fitted in the map. (F) Comparison of structures of SARM1 WT (colored in yellow) and 2Cmut (colored by domains) in complex with M1. (G) Close-up view of the secondary binding interface. A portion of the BB loop (e.g., D605 and E604) in the structure of 2Cmut is resolved through interactions with the ARM domain (e.g., K173). (H) EM density of the disulfide bond in the 2Cmut at a contour level of 4σ.

Article Snippet: Similarly, 0.1 μg/μL SARM1 (WT) was incubated with 500 μM DSARM (MCE) and 500 μM NAD+ (MCE) in DPBS buffer containing an additional 150 mM NaCl and rotated at room temperature overnight.

Techniques: Activation Assay, Plasmid Preparation, Expressing, Purification, Incubation, Cryo-EM Sample Prep, Comparison, Binding Assay